A new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 6, 2010, Pages 821-827

  Zhang, Bai Hong ^a   Wang, Xiang Hui ^a   Yue, Hong Yun ^a   Ling, Chang Quan ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Staging; Survival; Validity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 77951632075     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-009-0722-1     Document Type: Article

References (12)

1. Cho YK, Chung JW, Kim JK et al (2008) Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer 112(2):352-361
2. Daniele B, Annunziata M, Barletta E et al (2007) Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinoma. Hepatol Res 37(Suppl 2):S206-S209
3. Farinati F, Rinaldi M, Gianni S et al (2000) How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer 89(11):2266-2273
4. Kitai S, Kudo M, Minami Y et al (2008) A new prognostic staging system for hepatocellular carcinoma: value of the biomarker combined Japan integrated staging score. Intervirology 51(Suppl 1):86-94
5. Llovet JM, Fuster J, Bruix J (2002) Prognosis of hepatocellular carcinoma. Hepatogastroenterology 49(43):7-11
6. Mendizabal M, Reddy KR (2009) Current management of hepatocellular carcinoma. Med Clin North Am 93(4):885-900
7. Okuda K, Ohtsuki T, Obata H (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 56(4):918-928
8. Said A, Wells J (2009) Management of hepatocellular carcinoma. Minerva Med 100(1):51-68
9. The Cancer of the Liver Italian Program (CLIP) Investigators (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28(3):751-755
10. Thimme R, Neagu M, Boettler T et al (2008) Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma. Hepatology 48(6):1821-1833
11. Toyama T, Hiramatsu N, Yakushijin T et al (2008) A new prognostic system for hepatocellular carcinoma including recurrent cases: a study of 861 patients in a single institution. J Clin Gastroenterol 42(3):317-322
12. Yau T, Yao TJ, Chan P et al (2008) A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials. Cancer 113(10):2742-2751